High-Quality PBMCs for Covid-19 Research

Covid-19 Human PBMC products are sourced from donors clinically diagnosed with Covid-19 and processed under stringent conditions to support immunology research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies on immune dysregulation, cytokine response, and therapeutic screening for Covid-19-related inflammation.

Product Features

• Research Use Only (RUO), cryopreserved PBMC
• Clinically confirmed Covid-19 donors
• Available in cell counts ranging from 5 million to 2 billion
• Processed within 24 hours of collection
• Stored using CryoStore® CS10 freezing media
• IRB-approved protocols and electronic informed consent
• Screen LeukoLot™ available prior to bulk orders

Donor Metadata

• Verified Covid-19 diagnosis
• Donor demographics: age, sex assigned at birth, race/ethnicity
• Self-reported allergies and infectious disease history
• Additional Covid-19-specific data available upon request

Applications

• Biomarker discovery and validation
• Drug screening and therapeutic development
• Immune pathway analysis in Covid-19 pathophysiology
• Transcriptomic and proteomic profiling

Quality and Compliance

• IRB-approved collections and protocols
• 21 CFR Part 11 – compliant e-consent system
• HIPAA-compliant donor data protection

Ordering & Shipping

Covid-19 PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact to confirm documentation and compliance needs.